REVIEW
Add like
Add dislike
Add to saved papers

Aesthetic canthal suspension.

Support of the lower eyelid with canthal suspension is a useful tool in the prevention of complications of lower blepharoplasty with particular relevance to eyelids with increased lower lid laxity, relatively prominent globes, and negative vector configuration of the eyelid-cheek junction. Caution is required in surgical management of this highly delicate anatomic area, as relatively small adjustments can result in relatively large changes that can alter the shape and appearance of the lower eyelids. Management options include canthopexy, orbicularis sling, and modified canthoplasty. The most conservative surgical management option is canthopexy, which supports the lower eyelid over either the short or long term. The use of the orbicularis sling technique avoids surgery around the relatively complex lateral canthus, but may not be suitable for cases without a need for a skin incision or a history of dry eye. Canthoplasty is generally reserved for more marked laxity, which is less common in the group of patients seeking aesthetic blepharoplasty.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app